[go: up one dir, main page]

AR012730A1 - Compuestos derivados de aminocicloalquilpirrolidina sustituida cis-sustituidos, droga, agente antimicrobiano y compuesto intermediario - Google Patents

Compuestos derivados de aminocicloalquilpirrolidina sustituida cis-sustituidos, droga, agente antimicrobiano y compuesto intermediario

Info

Publication number
AR012730A1
AR012730A1 ARP980102355A ARP980102355A AR012730A1 AR 012730 A1 AR012730 A1 AR 012730A1 AR P980102355 A ARP980102355 A AR P980102355A AR P980102355 A ARP980102355 A AR P980102355A AR 012730 A1 AR012730 A1 AR 012730A1
Authority
AR
Argentina
Prior art keywords
group
carbon atoms
substituted
alkyl group
drug
Prior art date
Application number
ARP980102355A
Other languages
English (en)
Original Assignee
Daiichi Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Seiyaku Co filed Critical Daiichi Seiyaku Co
Publication of AR012730A1 publication Critical patent/AR012730A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C07D207/09—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/20—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36—Oxygen or sulfur atoms
    • C07D207/38—2-Pyrrolones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)

Abstract

Compuestos derivados de aminocicloalquilpirrolidina sustituida cis-sustituidos de formula (I) donde R1 representa un átomo de hidrogeno o ungrupo alquilo que tiene 1 a 6 átomos de carbono; R2 representa un átomo de hidrogeno o un grupo alquilo que tiene 1 a 6 átomos de carbono, siempre que elgrupo alquilo pueda tener uno o más sustituyentes seleccionados del grupo formado por un grupo hidroxilo, un átomo de halogeno y un grupo alcoxilo quetiene hasta 6 átomos de carbono;R3 y R5 representan cada uno lun átomo de hidrogeno; R4 representa un grupo hidroxilo, un átomo de halogeno, un grupocarbamoilo, un grupo alquilo que tiene entre 1 a 6 átomos de carbono, un grupo alcoxilo que tiene 1 a 6 átomos de carbono o ungrupo alquiltio que tiene 1 a 6átomos de carbon, siempre que el grupo alquilo pueda tener uno o más sustituyentes seleccionados del grupo formado por un grupo hidroxilo, un átomode halogeno y un grupo alcoxilo que tiene 1 a 6 átomos de carbono; y R4 y el sustituyente en el anillo pirrolidina de la formula (II) están ubicados en laconfiguracion cis: R6 y R7 representan cada uno independientemente un átomo de hidrogeno o un grupo alquilo que tiene entre 1 y 6 átomos de carbono; N esunentero entre 1 y 3 ; y Q representa una estructura parcial representada por la formula (III). Los derivados de aminocicloalquilpirrolidina se usan comoprincipio activo en una droga y como agente antimicrobiano. También se incluye un intermediario en la preparacion de los derivados deaminocicloalquilpirrolidina.
ARP980102355A 1997-05-21 1998-05-21 Compuestos derivados de aminocicloalquilpirrolidina sustituida cis-sustituidos, droga, agente antimicrobiano y compuesto intermediario AR012730A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP13141397 1997-05-21
JP14064397 1997-05-29

Publications (1)

Publication Number Publication Date
AR012730A1 true AR012730A1 (es) 2000-11-08

Family

ID=26466258

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP980102355A AR012730A1 (es) 1997-05-21 1998-05-21 Compuestos derivados de aminocicloalquilpirrolidina sustituida cis-sustituidos, droga, agente antimicrobiano y compuesto intermediario

Country Status (14)

Country Link
US (1) US20020077345A1 (es)
EP (1) EP1020459B1 (es)
KR (1) KR20010012740A (es)
CN (1) CN1263527A (es)
AR (1) AR012730A1 (es)
AT (1) ATE292632T1 (es)
AU (1) AU7449398A (es)
BR (1) BR9810235A (es)
CA (1) CA2289605A1 (es)
DE (1) DE69829682T2 (es)
ID (1) ID24434A (es)
IL (1) IL132982A0 (es)
NO (1) NO995653L (es)
WO (1) WO1998052939A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU735186B2 (en) 1997-09-15 2001-07-05 Warner Chilcott Company, Llc Antimicrobial quinolones, their compositions and uses
WO2000054811A1 (en) 1999-03-17 2000-09-21 Daiichi Pharmaceutical Co., Ltd. Medicinal compositions
JP4180366B2 (ja) * 2000-10-12 2008-11-12 第一三共株式会社 抗菌性化合物製造用原料化合物の製法およびその中間体
ES2292642T3 (es) 2000-11-20 2008-03-16 Daiichi Sankyo Company, Limited Compuestos deshalogenados.
ES2249489T3 (es) 2000-12-14 2006-04-01 THE PROCTER & GAMBLE COMPANY Quinolonas antimicrobianas.
HUP0303457A3 (en) 2000-12-14 2008-05-28 Procter & Gamble Antimicrobial 2-pyridones, compositions containing them and their use
ES2402420T3 (es) * 2003-09-29 2013-05-03 Daiichi Sankyo Company, Limited Derivado del ácido 8-cianoquinolonacarboxílico
EP1999125A2 (en) 2006-03-28 2008-12-10 The Procter and Gamble Company A coupling process for preparing quinolone intermediates
AU2007230630B2 (en) 2006-03-28 2012-12-20 Taigen Biotechnology Co., Ltd Malate salts, and polymorphs of (3S,5S)-7-[3-amino-5-methyl-piperidinyl]-1-cyclopropyl-1,4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylic acid
CA3051126A1 (en) 2017-01-25 2018-08-02 Robert Vidlund Blood vessel access and closure devices and related methods of use

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL79189A (en) * 1985-06-26 1990-07-12 Daiichi Seiyaku Co Quinoline and/or naphthyridine-4-oxo-3-carboxylic acid derivatives,process for their preparation and pharmaceutical compositions comprising them
JPH0674261B2 (ja) * 1988-06-21 1994-09-21 塩野義製薬株式会社 キノロンカルボン酸誘導体
US5726182A (en) * 1990-05-02 1998-03-10 Abbott Laboratories Quinolizinone type compounds
US5580872A (en) * 1990-05-02 1996-12-03 Abbott Laboratories Quinolizinone type compounds
US5157128A (en) * 1990-11-30 1992-10-20 Warner-Lambert Company Certain optically active substituted α,α-dialkyl-pyrrolidine-3-methamines useful as intermediates
JPH09503783A (ja) * 1993-10-14 1997-04-15 アボツト・ラボラトリーズ キノリジノン型化合物
JP3745433B2 (ja) * 1995-02-02 2006-02-15 第一製薬株式会社 複素環式化合物
PT911328E (pt) * 1995-11-22 2006-05-31 Daiichi Seiyaku Co Derivados susbstituidos de aminocicloalquilpirrolidina

Also Published As

Publication number Publication date
BR9810235A (pt) 2001-09-18
ATE292632T1 (de) 2005-04-15
DE69829682T2 (de) 2006-03-09
KR20010012740A (ko) 2001-02-26
AU7449398A (en) 1998-12-11
EP1020459A1 (en) 2000-07-19
EP1020459B1 (en) 2005-04-06
NO995653D0 (no) 1999-11-18
DE69829682D1 (de) 2005-05-12
CN1263527A (zh) 2000-08-16
NO995653L (no) 2000-01-21
IL132982A0 (en) 2001-03-19
ID24434A (id) 2000-07-20
CA2289605A1 (en) 1998-11-26
WO1998052939A1 (en) 1998-11-26
US20020077345A1 (en) 2002-06-20
EP1020459A4 (en) 2001-03-07

Similar Documents

Publication Publication Date Title
HUP9802822A2 (hu) Halogén-benzimidazol-származékok, intermedierjeik, előállításuk és a vegyületeket hatóanyagként tartalmazó mikrobicid készítmények
AR050917A1 (es) Compuestos basados en 2-amido-tiazol que presentan actividad inhibidora de enzimas que utilizan atp, y composiciones y usos de los mismos
NO20013379D0 (no) 4-okso-1,4-dihydro-3-kinolinkarboksamider som antivirusmidler
CO5640136A2 (es) Derivados de hexahidropiridoisoquinolinas inhibidores de dpp-iv y composiciones farmaceuticas que los contienen
DE60214591D1 (en) Pyrazolpyrimidinfungizide
DE60129210D1 (de) Zyklische amid-derivate
AR013184A1 (es) Aminas heterociclicas espiroazobiciclicas, composicion farmaceutica, uso de dichas aminas para preparar medicamentos y metodo de tratamiento o profilaxis
NO20010228L (no) Farmasøytiske preparater omfattende 2-kinoloner
DE69507293D1 (de) Benzamid-derivate als vasopressin-antagonisten
UY24010A1 (es) Nuevos pirrolocarbazoles
ATE277042T1 (de) Antimikrobielle 4-oxochinolizine mit 2- pyridongerüsten als teilstruktur
AR012730A1 (es) Compuestos derivados de aminocicloalquilpirrolidina sustituida cis-sustituidos, droga, agente antimicrobiano y compuesto intermediario
IT1315267B1 (it) Derivati di 2-(1h-indol-3-il)-2-oxo-acetammidi ad attivita'antitumorale
SE8505887L (sv) Indoler
MY138466A (en) Aminoalkoxyndoles as 5-ht6-receptor ligands for the treatment of cns-disorders
ATE172454T1 (de) Pyridazinon derivate mit pharmazeutischer wirkung
TW200504059A (en) Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
ES433462A1 (es) Un procedimiento de produccion de un derivado de pirazina.
EA200602176A1 (ru) Производные тетрагидроизохинолилсульфонамидов, их получение и применение в терапии
TW333532B (en) Benzopyrans
ES2119874T3 (es) Nuevos derivados de elipticina, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
HRP20070286T3 (en) Substituted diketopiperazines and their use as oxytocyn antagonists
ES420253A1 (es) Un procedimiento para preparar nuevos derivados de 2-ami- noindano.
MX9305719A (es) Agente antiarritmico.
HRP20010885B1 (en) Ethanesulfonyl-piperidine derivatives

Legal Events

Date Code Title Description
FB Suspension of granting procedure